Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Gan To Kagaku Ryoho ; 44(12): 1901-1903, 2017 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-29394814

RESUMO

A 75-years-old man was diagnosed with a cystic submucosal tumor of the middle body of the stomach and diffuse cystic malformation. Laparoscopic total gastrectomy was performed since a type II c gastric cancer was found at the lower body of the stomach after 1-year follow-up. Histopathological examination revealed mucosal adenocarcinoma with diffuse cystic malformation. Strict observation and appropriate treatment are needed for diffuse cystic malformation because of its significant carcinogenic rate.


Assuntos
Adenocarcinoma/cirurgia , Mucosa Gástrica/cirurgia , Neoplasias Gástricas/cirurgia , Idoso , Cistos/cirurgia , Gastrectomia , Mucosa Gástrica/patologia , Humanos , Laparoscopia , Masculino , Neoplasias Gástricas/patologia
2.
Gan To Kagaku Ryoho ; 37(1): 131-3, 2010 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-20087047

RESUMO

The patient was a 70-year-old woman, who had undergone total gastrectomy and splenectomy with D2 lymph node dissection, for stage II gastric cancer. We admitted S-1 of 80 mg/day in adjuvant chemotherapy on postoperative day 28. There were no adverse events for one week, and she was discharged. Severe diarrhea occurred 6 days following discharge, but she continued to take S-1. Two weeks after discharge, she visited our hospital, suffering from severe dehydration (grade 4), leucopenia (grade 4)and thrombocytopenia (grade 3). Unfortunately, she died of lung edema and multiple organ failure 28 days after chemotherapy. We measured the mRNA expression level of dihydropyrimidine dehydrogenase (DPD) of the patient's liver by the Dannenberg Tumor Profile method. The expression level of DPD was significantly low, so we suggested that the severe bone marrow suppression might have been caused by the disordered metabolism of 5-FU.


Assuntos
Antimetabólitos Antineoplásicos/efeitos adversos , Medula Óssea/efeitos dos fármacos , Deficiência da Di-Hidropirimidina Desidrogenase , Ácido Oxônico/efeitos adversos , Neoplasias Gástricas/terapia , Tegafur/efeitos adversos , Idoso , Quimioterapia Adjuvante , Combinação de Medicamentos , Feminino , Gastrectomia , Humanos , Fígado/enzimologia , Excisão de Linfonodo , Esplenectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA